The DEXA-SEPSIS study protocol: a phase II randomized double-blinded controlled trial of the effect of early dexamethasone in high-risk sepsis patients
Kihwan Choi, Jong Eun Park, Anhye Kim, Sojung Hwang, Jinkun Bae, Tae Gun Shin, Kyuseok Kim
Clin Exp Emerg Med. 2022;9(3):246-252.   Published online 2022 Sep 20     DOI: https://doi.org/10.15441/ceem.22.276
Citations to this article as recorded by Crossref logo
Dysregulated dendritic cells in sepsis: functional impairment and regulated cell death
Li-yu Zheng, Yu Duan, Peng-yi He, Meng-yao Wu, Shu-ting Wei, Xiao-hui Du, Ren-qi Yao, Yong-ming Yao
Cellular & Molecular Biology Letters.2024;[Epub]     CrossRef
Effects of NF-κB Inhibitor on Sepsis Depend on the Severity and Phase of the Animal Sepsis Model
Ye Jin Park, Jinkun Bae, Jae-Kwang Yoo, So-Hee Ahn, Seon Young Park, Yun-Seok Kim, Min Ji Lee, Seon Young Moon, Tae Nyoung Chung, Chulhee Choi, Kyuseok Kim
Journal of Personalized Medicine.2024; 14(6): 645.     CrossRef
High expression of L-GILZ transcript variant 1 (GILZ TV 1) is associated with increased 30-day sepsis mortality, and a high expression ratio possibly contraindicates hydrocortisone administration
Stefan Rusev, Patrick Thon, Birte Dyck, Dominik Ziehe, Tim Rahmel, Britta Marko, Lars Palmowski, Hartmuth Nowak, Björn Ellger, Ulrich Limper, Elke Schwier, Dietrich Henzler, Stefan Felix Ehrentraut, Lars Bergmann, Matthias Unterberg, Michael Adamzik, Björ
Critical Care.2024;[Epub]     CrossRef